Nuwellis Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nuwellis has been growing earnings at an average annual rate of 1.9%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 9% per year.

Anahtar bilgiler

1.9%

Kazanç büyüme oranı

84.9%

EPS büyüme oranı

Medical Equipment Sektör Büyümesi8.9%
Gelir büyüme oranı9.0%
Özkaynak getirisin/a
Net Marj-253.1%
Sonraki Kazanç Güncellemesi11 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Nuwellis hires Lynn Blake as CFO

Oct 19

Nuwellis surges 90% on positive data from Postoperative Coronary Artery Bypass Grafting treatment

Aug 31

Nuwellis Q2 2022 Earnings Preview

Aug 08

CHF Solutions down 10% on Q3 miss

Nov 10

Gelir ve Gider Dağılımı

Nuwellis nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqCM:NUWE Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 249-23154
31 Mar 249-20165
31 Dec 239-23175
30 Sep 239-17185
30 Jun 238-17195
31 Mar 238-17195
31 Dec 229-15184
30 Sep 228-17174
30 Jun 228-18175
31 Mar 228-19185
31 Dec 218-20195
30 Sep 218-18195
30 Jun 218-17194
31 Mar 218-17184
31 Dec 207-18174
30 Sep 207-19174
30 Jun 206-19174
31 Mar 206-20174
31 Dec 196-23165
30 Sep 196-22165
30 Jun 196-22165
31 Mar 195-22154
31 Dec 185-17153
30 Sep 184-29143
30 Jun 184-27132
31 Mar 184-27122
31 Dec 174-25101
30 Sep 173-14102
30 Jun 173-1593
31 Mar 172-1685
31 Dec 161-1878
30 Sep 161-19712
30 Jun 160-22715
31 Mar 160-24816
31 Dec 150-27818
30 Sep 150-27918
30 Jun 150-26917
31 Mar 150-26918
31 Dec 140-26917
30 Sep 140-261016
30 Jun 140-261016
31 Mar 140-241015
31 Dec 130-22914

Kaliteli Kazançlar: NUWE is currently unprofitable.

Büyüyen Kar Marjı: NUWE is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NUWE is unprofitable, but has reduced losses over the past 5 years at a rate of 1.9% per year.

Büyüme Hızlandırma: Unable to compare NUWE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: NUWE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).


Özkaynak Getirisi

Yüksek ROE: NUWE's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin